Sareum Holdings Plc (LON:SAR)

Sareum Holdings Plc (LON:SAR)


Share Price
0.85 p
Change
0.035 (4.29 %)
Market Cap
£24.45 m
Proactive Investors - Run By Investors For Investors

Sareum Holdings Plc

Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.

EPIC: SAR
Market: AIM:SAR
52-week High/Low: 0.95p / 0.45p
Sector: Pharma & Biotech
Market Cap: £24.45 m
Website: www.sareum.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Sareum Holdings Plc


1550850611_CancerHeadline.jpg
Broker Hybridan reckons Sareum is “arguably a bargain target for the relatively large group of biotech and pharma companies interested in TYK2 and the wider JAK inhibitor space”

Sareum Holdings Plc Timeline

Article

Sareum Holdings primed for progress

Broker Hybridan reckons Sareum is “arguably a bargain target for the relatively large group of biotech and pharma companies interested in TYK2 and the wider JAK inhibitor space”

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use